About Maik Jornitz
Form D filings for Sunflower Therapeutics, PBC from 2022 to 2024 list Maik Jornitz as director.
Maik Jornitz first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Maik Jornitz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Maik Jornitz works with at each company, as listed on that company's latest Form D.
Sunflower Therapeutics, PBC · Form D, May 24, 2024